IQVIA (NYSE:IQV – Free Report) had its price objective cut by Evercore ISI from $275.00 to $250.00 in a report issued on Friday morning, Benzinga reports. They currently have an outperform rating on the medical research company’s stock. IQV has been the topic of a number of other reports. UBS Group boosted their target price […]
Power Wealth Management LLC purchased a new stake in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm purchased 2,497 shares of the medical research company’s stock, valued at approximately $578,000. A number of other hedge funds […]
Forte Capital LLC ADV cut its stake in IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 4.9% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 37,650 shares of the medical research company’s stock after selling 1,920 shares during the period. […]
IQVIA (NYSE:IQV – Get Free Report) had its price objective decreased by equities researchers at Evercore ISI from $275.00 to $250.00 in a report released on Friday, Benzinga reports. The brokerage presently has an “outperform” rating on the medical research company’s stock. Evercore ISI’s price target would suggest a potential upside of 11.91% from the […]
Natixis Advisors L.P. lifted its position in shares of IQVIA Holdings Inc. (NYSE:IQV – Free Report) by 12.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 168,910 shares of the medical research company’s stock after purchasing an additional 18,469 shares during […]